Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression

Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy

(2014) Marek Kaciński et al.   Pharmacological Reports

Neuron specific enolase and serum remain unaffected by ultra high frequency left prefrontal transcranial magnetic stimulation in patients with depression: a preliminary study

(2013) Heiko Ullrich et al.   JOURNAL OF NEURAL TRANSMISSION

Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients

(2012) Viktoria Stelzhammer et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Serum S100B levels in children with simple febrile seizures

(2012) Yeliz Atici et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

S100B proteins in febrile seizures

(2012) Kirsi Mikkonen et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

(2011) Sube Banerjee et al.   LANCET

Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis

(2010) Maria Semkovska et al.   BIOLOGICAL PSYCHIATRY

Factors That Influence Electroconvulsive Therapy Referrals

(2010) Laura E. Dauenhauer et al.   JOURNAL OF ECT

Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein

(2010) Johanna Palmio et al.   PSYCHIATRY RESEARCH